Vanillic Acid from Cayman Chemical

Supplier Page

Supplier Page from
Cayman Chemical for
Vanillic Acid

Request Info

Description

A phenol with diverse biological activities; inhibits biofilm formation by CREH (MIC = 0.8 mg/ml); inhibits doxorubicin-induced cell death in H9c2 rat cardiomyocytes at 12 µg/ml; reduces cardiac levels of lactate dehydrogenase, cardiac troponin-1, and MDA in a rat model of doxorubicin-induced cardiotoxicity at 10, 20, and 40 mg/kg; reduces hyperglycemia and renal levels of TBARS, TNF-α, and NF-κB, as well as attenuates impaired renal function in a rat model of STZ- and nicotinamide-induced diabetes; reduces BALF inflammatory cell infiltration and airway inflammation in a rat model of ovalbumin-induced asthma at 25 and 50 mg/kg